4th Quarter - Report
DOW LOHNES GOVERNMENT STRATEGIES LLC for AMGEN, INC.
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biosimilars Legislation H.R.1038 - Access to Life Saving Medicine Act H.R.1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 FDA Drug Safety Oversight H.R.5629 - Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC S KESSLER | Chief of Staff, Hon. John D. Dingell |
| JESSICA M LENARD | Legislative Assistant, Hon. Richard J. Durbin |
| PETE LEON | Legislative Director, Hon. Eliot Engel |
Medicare/Medicaid MMM
Medicare Coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC S KESSLER | Chief of Staff, Hon. John D. Dingell |
| JESSICA M LENARD | Legislative Assistant, Hon. Richard J. Durbin |
| PETE LEON | Legislative Director, Hon. Eliot Engel |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.